High Pointe Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Curtiss-Wright
CW
|
+$1.67M |
| 2 |
Ziff Davis
ZD
|
+$1.52M |
| 3 |
FMC
FMC
|
+$1.28M |
| 4 |
Outfront Media
OUT
|
+$1.11M |
| 5 |
Agilent Technologies
A
|
+$851K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$1.57M |
| 2 |
FedEx
FDX
|
+$1.03M |
| 3 |
Johnson Controls International
JCI
|
+$765K |
| 4 |
DuPont de Nemours
DD
|
+$699K |
| 5 |
Chevron
CVX
|
+$695K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.69% |
| 2 | Materials | 15.94% |
| 3 | Industrials | 11.48% |
| 4 | Financials | 11.12% |
| 5 | Communication Services | 8.09% |
Similar funds
High Pointe Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, High Pointe Capital Management held 92 positions worth $84.3M, up 15% from $73.1M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
High Pointe Capital Management deployed $3.48M of net new capital in Q4 2019, opening 11 new positions and adding to 16 existing holdings. Its largest new stake was Curtiss-Wright: 12,315 shares worth $1.74M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Materials and Industrials.
On the sell side, the largest reduction was Chevron, an estimated $695K trimmed.
- High Pointe Capital Management's largest Q4 2019 buy was Curtiss-Wright: 12,315 shares worth $1.74M.
- High Pointe Capital Management added most to FMC in Q4 2019, an estimated $1.28M increase.
- High Pointe Capital Management's biggest Q4 2019 reduction was Chevron, cutting an estimated $695K.
- High Pointe Capital Management fully exited Boston Scientific in Q4 2019, selling an estimated $1.57M.
- High Pointe Capital Management's ten largest holdings make up 31% of its $84.3M portfolio in Q4 2019.
- High Pointe Capital Management opened 11 new positions and closed 12 in Q4 2019.
- High Pointe Capital Management's portfolio value rose 15% quarter-over-quarter to $84.3M.
Based on High Pointe Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.